← Leaderboards
Meera J Kelly
University Of North Carolina Chapel Hill
$676,049
Attributed
$676,049
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$676,049 · 1
By mechanism
M01$676,049 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- John B Buse$71,388,050
- Charles Michael Van Der Horst$17,688,631
- Richard C Boucher$55,332,929
- Eugene P Orringer$33,565,484
- Steven H Zeisel$43,160,126
Others in their field
Top investigators on “Candidiasis”
- Wafaa M. El-Sadr · Columbia University Health Sciences$20,205,932
- Sarah L. Gaffen · University Of Pittsburgh At Pittsburgh$12,884,778
- Bruce W. Birren · Broad Institute, Inc.$11,623,320
- Daniel E Neafsey · Broad Institute, Inc.$11,623,320
- Scott G Filler · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center$11,529,865
- Michael C Lorenz · University Of Texas Hlth Sci Ctr Houston$11,145,912
Research focus
CandidiasisChronic Disease /DisorderClinical ResearchClinical TrialsFluconazoleHuman SubjectHuman Therapy EvaluationMicroorganism Disease Chemotherapy
Grant awards (7)
RANDOMIZED STUDY OF USE OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY$190,747
M01 · FY2002 · RR
RANDOMIZED STUDY OF USE OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY$294,555
M01 · FY2001 · RR
RANDOMIZED STUDY OF USE OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY$190,747
M01 · FY2001 · RR
FLUCONAZOLE IN HIV PTS W/ OROPHARYNGEAL CANDIDIASIS$0
M01 · FY2000 · RR
FLUCONAZOLE IN HIV PTS W/ OROPHARYNGEAL CANDIDIASIS$0
M01 · FY2000 · RR
FLUCONAZOLE IN HIV PTS W/ OROPHARYNGEAL CANDIDIASIS$0
M01 · FY2000 · RR
FLUCONAZOLE IN HIV PTS W/ OROPHARYNGEAL CANDIDIASIS$0
M01 · FY2000 · RR